Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

T-588 prevents retinal ganglion cell death in rats with elevated IOP

Jan. 29, 2003

FDA advisory committee to review Vitrase NDA

Jan. 29, 2003

Alcon claims three series of 5-HT2 agonists with utility in glaucoma therapy

Jan. 23, 2003

Novartis obtains rights to pirenzepine for myopia from Valley Forge

Jan. 20, 2003

InSite Vision finalizes ISV-401 phase III trial protocol

Jan. 20, 2003

Inspire prepares to submit NDA for diquafosol by mid-2003

Jan. 14, 2003

Restasis receives FDA approval

Jan. 7, 2003

FDA approval for Xalatan as first-line therapy for elevated IOP

Jan. 2, 2003

Pfizer and Eyetech form collaboration to develop and commercialize Macugen

Dec. 30, 2002

Statistically significant preliminary results in Visudyne study in minimally classic wet AMD

Dec. 27, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...